Analyst Michael Infante from Morgan Stanley maintained a Buy rating on Clearwater Analytics Holdings and keeping the price target at $27.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Michael Infante has given his Buy rating due to a combination of factors that highlight Clearwater Analytics Holdings’ promising future prospects. Despite a challenging year marked by skepticism over a major acquisition and concerns about the core business’s growth, Clearwater has demonstrated resilience. The company’s core business has shown a robust growth rate of approximately 21% year-to-date, and its EBITDA performance has been notably strong.
Infante is optimistic about Clearwater’s trajectory into 2026, driven by several key elements. These include anticipated high-teens growth in the core business, contributions from recent significant deals that have yet to fully impact ARR, and the acceleration of Enfusion growth. Additionally, the company is expected to benefit from revenue and ARR tailwinds due to lower rates, as well as contributions from cross-selling initiatives and partnerships like the one with Bloomberg. Overall, Infante remains positive about Clearwater’s ability to provide clarity on revenue growth in the near to medium term, which should alleviate stock pressure.
According to TipRanks, Infante is an analyst with an average return of -5.9% and a 37.50% success rate.
In another report released today, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $22.00 price target.

